Editorial draft · writing/ergot-and-the-pharmacist
Ergot and the Pharmacist's Daughter
Education, not medical advice. Drafts and study material from an independent research library. Citations on this page were checked on Oct 13, 2026; claims in the body text and organizational sources are still under review. What was checked.
Ergot and the Pharmacist's Daughter
“Ergot had been trying to get Hofmann's attention for years. It was the fung…”historypharmacology
“Ergot had been trying to get Hofmann's attention for years. It was the fungus that stopped postpartum hemorrhage, caused the Dancing Plague of 1374, and eventually, through his hands, became LSD.”
Albert Hofmann joined the Basel drug company in Basel in 1929 and was assigned to study ergot, the fungus Claviceps purpurea, which grows on rye and other grains and had been known since antiquity for two completely opposite properties.
The first: it caused uterine contractions, making it useful for stopping postpartum hemorrhage. Midwives in medieval Europe had used ergot-contaminated rye for this purpose, passing the knowledge through generations without understanding the mechanism.
The second: it caused what medieval observers called St. Anthony's Fire, a syndrome combining hallucinations, convulsions, burning sensations in the extremities, and sometimes gangrene. The Paris epidemic of 1418 killed fifty thousand people. The Dancing Plague of 1374, in which hundreds of people danced uncontrollably for days, is now attributed to ergot in the grain supply. The Salem witch trials may have been ergot poisoning.
Hofmann's task at the company was to isolate the medically useful alkaloids from ergot and develop pharmaceutical derivatives. He succeeded with ergotamine and ergobasine, both of which became important drugs. In 1938, pursuing the pharmaceutical potential further, he synthesized a derivative of lysergic acid, the backbone structure common to all ergot alkaloids, and called it LSD-25. It was the twenty-fifth compound in the lysergic acid series. The animal tests showed nothing interesting. He filed it and moved on.
Five years later, for reasons he described as a 'peculiar presentiment', he returned to LSD-25. In the final stages of the synthesis, he absorbed a small amount through his skin. The rest is what we know.
What connects ergot's two properties, the obstetrical and the hallucinogenic, is the chemistry of the ergot alkaloids and their action on serotonin receptors. The same receptor family that controls uterine muscle contraction is implicated in the perceptual effects of LSD. Hofmann, working at the boundary between these two pharmacological territories, accidentally synthesized the most potent psychoactive compound known. The fungus had been hiding it in plain sight for millennia.
Sources
- Hofmann, LSD: My Problem Child (1979)
- The Lancet, Albert Hofmann obituary (2008)
- Wacker et al., Cell (2017)
Links for this item
- Posts
- No post is recorded for this item yet.
- Source page
- The sources for this item on RN Collins Selected Work
- Long-form
- This page is the full draft.
- Gallery
- See it in the gallery index
- Project
- About this library on RN Collins Selected Work
- Corrections
- Publication rules and the correction form
Course modules that assign this draft
- The First Contacts Course module
Reading list for this book
- Reading list: LSD: My Problem Child Reading list
NotebookLM packs on this book
- April 19, 1943 NotebookLM source pack
Bridge pieces that use this book
- María Sabina and the Machine Elves: Two Accounts of Encountering the Other Bridge piece
- The Sacred Drug and the Dominator Drug: Hofmann and McKenna on Alcohol Bridge piece
Science annotations on this book
- A single psychedelic session can produce lasting psychological change persisting for months or years, not... Science annotation
Then vs. Now comparisons on this book
- LSD Potency: The Threshold Claim Then vs. Now comparison
- LSD and Mystical Experience: Hofmann's Claim Then vs. Now comparison
- LSD as Sacred Drug: The 1965 Prohibition Then vs. Now comparison
- Bicycle Day Chemistry: What Hofmann Synthesized Then vs. Now comparison
- LSD and the Law: Hofmann's Hope for Rescheduling Then vs. Now comparison
- LSD in Switzerland 2026: The Country That Never Stopped Then vs. Now comparison
- LSD's Crystal Structure and the Duration Mechanism Then vs. Now comparison
- Cluster Headaches and LSD: The Orphan Indication Hofmann Didn't Know About Then vs. Now comparison
- MDMA and LSD: Hofmann's Two 'Problem Children' Then vs. Now comparison
- The Neuroplasticity Mechanism: What Hofmann Couldn't Have Known Then vs. Now comparison
Claims from this book
- Mystical experience quality predicts therapeutic outcomes better than drug dose alone Claim
- Hofmann's LSD is best understood as a 'sacred drug' rather than a psychiatric tool Claim
- FDA approval of psilocybin-assisted therapy would make it broadly accessible to patients who need it Claim
- LSD is not addictive in the conventional sense, it does not produce physical dependence or compulsive use... Claim
- LSD microdosing (sub-perceptual doses) produces measurable cognitive benefits Claim
- A single psilocybin session can produce lasting reduction in tobacco addiction Claim
Other pages in this library that link here
- The Science of the Experience Course module
- The Suppression Course module
- Psychedelic Science for Science Writers Teaching module